December 2025
The global drug formulation market size is calculated at USD 1.96 trillion in 2025 and is projected to hit around USD 3.50 trillion by 2035 with a CAGR of 5.97%.
July 2026
The global AI-powered drug formulation market is growing as pharmaceutical companies leverage AI to optimize drug design, delivery, and efficacy.
August 2025
The global non-sterile liquids and suspensions market size was evaluated at USD 48.06 million in 2024 and is predicted to hit around USD 95.25 million by 2034, growing at a CAGR of 7.08%.
September 2026
The global intranasal drug delivery devices market size surpassed USD 2,043.63 million in 2026 and is projected to hit around USD 4,949.45 million by 2035, with a noteworthy CAGR of 10.33%.
September 2026
The global drug of abuse testing market size was estimated at USD 15.42 billion in 2026 and is projected to hit around USD 24.14 billion by 2035, with a notable CAGR of 5.11%.
September 2026
The global drug-eluting balloon catheters market size was valued at USD 1.70 billion in 2026 and is expected to hit around USD 4.28 billion by 2035, growing at a CAGR of 10.83%.
September 2026
The global epilepsy drug market size is projected to attain around USD 19.67 billion by 2035 USD 12.49 billion in 2026 with a CAGR of 5.17%.
September 2026
The global anti-obesity drugs market size is estimated at USD 8.96 billion in 2026, and is projected to hit around USD 64.96 billion by 2035, with a CAGR of 24.71%.
September 2026
The omega 3 prescription drugs market size was valued at USD 1.66 billion in 2026 and is projected to hit around USD 2.93 billion by 2034 with a CAGR of 7.36%.
September 2026
The global inhalable drugs market size was valued at USD 35.44 billion in 2024 and is projected to cross around USD 65.51 billion by 2034 with a CAGR of 5.57%.
September 2026
The genitourinary drugs market size was USD 30.37 billion in 2026, with leading genitourinary drugs market players including Pfizer inc, johnson & johnson, bayer ag, Sanofi.
September 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 18.24 billion in 2026, with a CAGR of 3.60%.
September 2026
The oral transmucosal drugs market size was valued at USD 41.82 billion in 2026 and is projected to attain around USD 70.37 billion by 2034 with a CAGR of 6.72%.
September 2026
The global 3D printed drugs market size was estimated at USD 400.73 million in 2026 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The global drug repurposing market size is estimated to hit around USD 62.24 billion by 2035, increasing from USD 38.87 billion in 2026, with a CAGR of 5.38%.
September 2026
The global alzheimers drug market size is estimated to hit around USD 7.53 billion by 2035 increasing from USD 4.43 billion in 2026, with a CAGR of 6.06%.
September 2026
The global transdermal drug delivery systems market size was evaluated at USD 87.46 billion in 2026 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
September 2026
The global nasal mucosa drug supply device market size was evaluated at USD 10.03 billion in 2026 and is predicted to hit around USD 19.71 billion by 2035, growing at a CAGR of 7.80%.
September 2026
The global UTI drugs market size was evaluated at USD 5.34 billion in 2026 and is predicted to hit around USD 8.65 billion by 2035, growing at a CAGR of 5.50%.
September 2026
The global smart drugs market size was evaluated at USD 2.54 billion in 2026 and is predicted to hit around USD 6.24 billion by 2035, growing at a CAGR of 10.50%.
September 2026
The global allergy rhinitis drugs market size is expected to increase from USD 15.17 billion in 2026 to hit around USD 21.61 billion by 2035, growing at a CAGR of 4.01%.
September 2026
The asthma drugs market was valued at USD 27.87 billion in 2026 and is expected to hit around USD 42.74 billion by 2035, growing at a CAGR of 4.46% from 2026 to 2035.
September 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
September 2026
The global HIV drugs market size is estimated at USD 40.86 billion in 2026 and is projected to hit around USD 69.88 billion by 2035, growing at a CAGR of 6.15%.
September 2026
The global atrial fibrillation drugs market size was evaluated at USD 16.54 billion in 2026 and is projected to surpass around USD 20.99 billion by 2034, with a CAGR of 3.02%.
September 2026
The global antidepressant drugs market size was evaluated at USD 20.09 billion in 2026 and is projected to cross around USD 26.06 billion by 2034, with a CAGR of 3.22%.
September 2026
The global companion animal drugs market size was evaluated at USD 17.01 billion in 2026 and is projected to reach around USD 29.42 billion by 2035, at a CAGR of 6.43%.
September 2026
The global liposome drug delivery market size reached USDÂ 6.63 billion in 2026 and is projected to surpass around USD 13.12 billion by 2034, with a CAGR of 8.91%.
September 2026
The global lipase inhibitors obesity drugs market size was estimated at USD 1.65 billion in 2026 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com